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Permeability and secondary membrane formation of a high flux
polysulfone hemofilter. It has been assumed that the molecular weight
(MW) cut—off of a newly fabricated polysulfone capillary dialyzer (F60,
Fresenius, FRO) is similar to that of the human glomerulus. We
recently tested the device in viva and found this not to be so, based on
the device's ability to eliminate substances of a MW of 10,000 to 60,000
daltons. One of the reasons for this discrepancy was found to be the
influence of secondary membrane formation on solute permeability.
Endogenous marker substances of a defined MW (2-microglobulin,
myoglobin, RBP, a1-microglobulin, acid a1-glycoprotein, a1-antitryp
sin, prealbumin, and albumin were measured by laser nephelometry or
radioimmune assay; sieving coefficients (SC) and protein eliminations
were calculated for each low MW protein.
During the first 10 mm of hemofiltration the dialyzer was
permeable to substances up to 66,000 daltons (albumin). Within
20 mm the permeability decreased to less than 30,000 daltons,
suggesting secondary membrane formation. Reuse with perace-
tic acid did not destroy the secondary membrane. Estimated
albumin loss was 1.4 0.7 g/20 liter filtrate with a new dialyzer
and less than 0.5 g with a reused membrane. According to our
studies, the in vivo cut—off of the polysulfone membrane is
comparable to that of the peritoneum.
Survivals of more than 20 years have been achieved for
patients on regular dialysis treatment (RDT). However, the rate
of mortality and morbidity is high and the quality of life of
patients on RDT is significantly less in comparison with renal
transplantation [1, 2]. Hematologic, immunologic, dermatolo-
gic, neurologic, and metabolic alterations are observed in
hemodialysis patients.
Middle molecular accumulation was suggested as a hypothet-
ical explanation for these uremic symptoms seen in patients on
conventional RDT, using cuprophane membranes with a cut—off
of about 400—3,000 daltons [3—5]. However, results concerning
the role of middle molecules in the pathogenesis of uremia is
controversial [6]. Beyond the middle molecule range the func
tioning kidney filters substances up to 65,000 daltons and
catabolizes low molecular weight (MW) proteins, peptides, and
hormones [7, 81.
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For this reason, besides biocompatibility issues [10—13], new
dialysis membranes have been developed. The polysulfone
membrane is typical for a new generation of hemofilters which
have high diffusive clearances for solutes of MW 60 to 5,000 as
well as high sieving coefficients (SC) for larger MW substances,
including small proteins [14]. The diffusive, convective, and
mixed performance characteristics of this dialyzer for urea,
crcatinine, phosphate, insulin and 132-microglobulin have been
reported by Schneider and Streicher [151. An SC of 0.79 for
J32-microglobulin was calculated for convective transport. The
aim of this study was to test this device for its ability to remove
possibly toxic substances of the higher MW range. Special
consideration was given to the effects of reuse and secondary
membrane formation.
Methods
Studies were performed on six patients on RDT (four male,
two female; aged 58.8 9.8 years; time on dialysis 46.2 28.3
months; three with polycystic disease, two with chronic gb-
merulonephritis, one with diabetic glomerulopathy). A polysul-
fone capillary dialyzer (Hemoflow F60, Fresenius, FRG) was
tested during first use and third reuse. At the beginning and the
end of their dialysis treatment patients were put on filtration for
20 and 10 minutes, respectively.
During filtration, the mean ultrafiltration rate (UFR) was 55
mI/mm with a new membrane (38 mI/mm with a reused mem-
brane), mean transmembraneous pressure (TMP) was 160 mm
Hg (200 mm Hg with reuse), and blood flow was constant at 200
mi/mm. The monitor used was the MTS 2008 (Fresenius, FRG).
For reuse, the capillaries were prepared with an automated
system (Renatron, Renal Systems Inc., Minneapolis, Minne-
sota USA) using peracetic acid (Acetoper 2000, Bionic, FRG)
as a cleansing and sterilizing agent. The main criteria for the
quality control of reused dialyzers were: at least 80% of original
fiber volume, few visible deposits, and a passed pressure test.
Patients' serum samples were obtained at time 0 (Cb 0) and
180 minutes (Cb 180); ultrafiltrate samples were taken at time 0,
30, 60, 90 seconds and 2, 5, 10, 20, 180 minutes after the start of
treatment, Samples were stored in fractions in polyethylene
tubes at a temperature of —70°C and thawed only once for
analysis. The marker substances albumin (66,290 daltons),
preabbumin (54,900 dallons), a1-antitrypsin (54,000 daltons),
acid a1-glycoprotein (41,000), a1 -microglobulin (26,700 dal-
tons), and retinol—binding—protein (RBP) (21,000 dabtons) were
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Protein SC First use Reuse
/32-microglobulin PSC 0.76 0.03 0.58 0.02
(11,818 daltons) SC 20
sc 180
0.60 0.02*
0.52 0.03*
0.58 0.02
0.49 0.02*
Myoglobin PSC 0.25 0.03 0.06 0.01
(17,200 daltons) SC 20
Sc 180
0.11 0.02*
0.11 0.0l
0.06 0.01
0.04 0.0I',
Retinol—binding PSC 0.09 0.01 0.01 0.01
protein SC 20 0.04 0.01* 0.01 0.01
(21,000 daltons) SC 180 0.03 0.01 0.01 0.01k
a1—niicroglobulin sc 0.10 0.01 0.01 0.01
(26,700 daltons) SC 20
SC 180
0.01 0.01
0.01 0.0l
0.01 0.01
0.01 0.01
1-glycoprotein PSC 0.05 0.01 <0.01
(41,000 daltons) SC 20
SC 180
<0.01*
<0,01*
<0.01
<0.01
a1-antitrypsin PSC 0.03 0.01 <0.01
(54,000 daltons) SC 20
Sc 180
<0.01k
<0.01*
<0.01
<0.01
Prealbumin PSC <0.01 <0.01
(54,980 daltons) SC 20
sc 180
<0.01
<0.01
<0.01
<0.01
Albumin PSC 0.02 0.01 <0.01
(66,290 daltons) SC 20
SC 180
<0.01
<0.01
<0.01
<0.01
analysed by laser nephelometry using rabbit antisera (Behring,
FRG . Myoglobin (17,200 daltons, Mallinckrodt, FRG) and
2-microglobulin (11,818 daltons, Pharmacia, Uppsala, Swe-
den) were determined by radioimmune assay. For the evalua-
tion of membrane permeability, the sieving coefficients (Sc)
were calculated using the concentration in the afferent blood
line (Cb) and in the ultrafiltrate (Cf according to the following
formula:
Cf
sc =
Cb
For calculation of SCs during the first 20 minutes Ch 0, for the
three hour SCs, Cb 180 was used. Significances were calculated
using the Wilcoxon ranked sum test. Protein elimination was
estimated by calculating the area under curve (protein concen-
tration versus ultrafiltrate flow). For comparison with a
hemofiltration therapy the values were computed in nig/20 liter
ultrafiltrate.
Results
Table I shows the peak sieving coefficients (PSC) and sieving
coefficients at 20 mm (SC 20) and 180 mm (SC 180) after the
start of ultrafiltration using new and reused membranes. During
the first 10 mm of treatment, the new membrane was permeable
to substances of a MW up to 66,290 daltons (albumin); The
higher the MW of substances was, the lower was their PSC
(0.76 0.06 for -microglobulin, 0.02 0.01 for albumin).
Twenty mm after the start of ultrafiltration, the permeability
had decreased significantly (P < 0.05); thereafter only sub-
stances of less than 30,000 daltons were filtered. The higher the
MW of substances was, the stronger was their decrease of SCs
during the first 20 mm (21% decrease for 2-microglobulin, 60%
decrease for a1-antitrypsin). Reused membranes were signifi-
cantly less permeable to myoglobin and RBP than new ones;
they showed no decline of permeability during dialysis.
Figure 1 shows the PSC and SC 20 of new membranes in
:omparison the SC 20 of reprocessed dialyzers.
Figure 2 shows the SCs of each low MW protein during the
time course of hemofiltration comparing new and reused mem-
branes. The values of prealbumin and retinol..-binding—protein
(RBP) were excluded from this curve since their SCs were
falsely low, probably due to their high plasma protein binding.
The three proteins with a MW of more than 40,000 daltons
(albumin, a1-antitrypsin, and acid a1-glycoprotein) had a PSC of
less than 0.05 with a new and less than 0.01 with a reused
dialyzer. They became undetectable in the ultrafiltrate after the
first few minutes of treatment. a1-mieroglobulin (26,700 dal-
tons) had a PSC of less (han 0.10 with first use and less than 0.01
with reuse, It was the largest protein detectable at 180 mm of
both first use and reuse filtration.
Figures 2 and 3 show the correlation between the time of
maximum permeability (PSC) and the MW of each plasma
protein; the higher the MW of a substance was, the earlier the
PSC occurred and the faster did the SC decrease.
Table 2 lists the calculated losses for each low MW protein
based on a ultrafiltrate volume of 20 liter. I)uring first use and
reuse hemofiltration the calculated albumin loss was 1.4 g and
less than 0.5 g, respectively.
Discussion
Protein and fibrin layer a deposit on membrane surfaces after
blood contact during hemodialysis, forming a secondary mem-
brane [161. The consequence is a decrease of ultrafiltration rate
and permeability, especially to substances of a MW greater than
5,000 daltons 17-19]. Because of the in vivo formation of
secondary membranes, in vitro studies using dextranes of
different molecular weights in aqueous solutions may be inad-
equate to investigate permeability properties of hemodialysis
membranes.
Table 1. Peak sieving coefficients (PSC) and sieving coefficients at 20
mm (SC 20) and 180 mm (SC 180) of low MW proteins (X sEM)
during hemofiltration with new and reused dialyzers°
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Fig. 1. Peak sieving coefficients (X SEM)of/ow MW proteins and SC
after 20 mm of hernoflurration with first used, and then reused F60
po/ysufone cap//tory dialyzers.
Significances (P < 0.05) between PSC and SC 20, Sc 180 (*), and
between SC 20, SC ISO in first used and reused membranes Cl were
tested.
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It was already shown that the protein adsorption on
polysulfone did not alter the membrane permeability for small
and middle molecular substances [14, 17]. The hyperbolic shape
of the curve in Figure 3 confirms these findings. The secondary
membrane seems to influence the permeability of substances up
to a certain MW only. The lower the MW of a substance, the
lesser the influence of the secondary membrane on its perme-
ability.
We evaluated membrane permeability characteristics during
the course of hemofiltration using endogenous marker sub-
stances with a defined MW between 11,800 and 66,200 daltons.
Under the prescribed conditions, the new polysulfone mem-
brane was well permeable for [32-microglobulin and myoglobin
throughout the treatment period. In the higher MW range
(above 40,000 daltons), the permeability was low (SC < 0.05)
before and neglegible after secondary membrane formation,
which we found to be completed within 20 mm after the start of
treatment.
This membrane was reported to have a cut—off comparable to
that of the glomerulus [20, 21], We found similar results at the
start of dialysis. However, taking into account the secondary
membrane formation, our findings demonstrate in vivo perme-
Protein First use loss Third reuse loss
/32-microglobulin 240 18 235 10
Myoglobin 465 103 224 26
Retinol—binding protein 145 17 38 3
a1-microglobulin 80 Il 36 4
a1-glycoprotein 162 40 <25
a1-antitrypsin 117 32 24 3
Prealbumin 22 2 <18
Albumin 1382 269 500
ability characteristics of this membrane to be similar to those of
the peritoneum [22, 23].
An important requirement in chronic high flux hemodialysis
treatment is the limitation of protein loss. This is nearly fulfilled
with an estimated albumin loss of only 1.4 g/20 liters filtrate with
first use and less than 0.5 g with reuse. The albumin loss during
the first use may be further minimized by using slow blood flow,
low TMP and UFR during the first 10 to 20 mm of treatment
until secondary membrane formation is complete. This proce-
dure is not necessary with a reused membrane since peracetic
acid does not destroy the secondary membrane. However,
dialysing at a low TMP and low UFR may result in backfiltra-
tion 1241 with consequent influx of LAL-positive substances
[251. These arguments might refute the recommendation for
membranes with even greater permeability.
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Fig. 3. Relationship between the 41W of plasma protein,s and the time
of their peak sieving coefficients during hemofiltration with first used
P60 polvsu/fone hemodialvzers.
Table 2. Calculated loss of plasma proteins ( SEM) during a 20
liters hemofiltration, comparing new and reused dialyzers.
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Fig. 2. Sieving coefficients (A' sEM) qf low MW proteins during
hemofiltration with first used (A), and then reused (B) P60 polvsuifone
hemodialyzers.
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